Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Capecitabine Teva

Capecitabine Teva 150 mg film-coated tablets Capecitabine Teva 500 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 15–16

HOS-215426 · Präparat HOS-155434

15  Body System Very Common Common Uncommon Rare/Very Rare (Post-Marketing All grades All grades Severe and/or Experience) Life-threatening (grade 3-4) or considered medically relevant Renal and - - Hydronephrosis, urinary disorders Urinary incontinence, Haematuria, Nocturia, Blood creatinine increased Reproductive - - Vaginal system and breast haemorrhage disorders General Fatigue, Asthenia Pyrexia, Oedema Oedema, Chills, disorders and peripheral, Influenza like administration Malaise, Chest illness, Rigors, site conditions pain Body temperature increased ** Based on the post-marketing experience, persistent or severe palmar-plantar erythrodysaesthesia syndrome can eventually lead to loss of fingerprints (see section 4.4)

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.